Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 17, 2025

Boehringer Ingelheim announces succession Chairmen Shareholders’ Committee and Board of Managing Directors
The Shareholders’ Committee of Boehringer Ingelheim have announced the following appointments in the Shareholders’ Committee and the Board of Managing Directors: Christian Boehringer, since 2007 Chairman of the Shareholders’ Committee, has decided to step …

Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award
ZUG, Switzerland, April 17, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical …

BlackRock® Canada Announces April Cash Distributions for the iShares® ETFs
TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the April 2025 cash distributions for the iShares ETFs listed …

FLYR Hospitality to Power Business Intelligence for Ennismore
SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- FLYR, the technology company that unlocks freedom to innovate for the travel industry, today announced that Ennismore, the fastest-growing lifestyle and leisure hospitality company, is working with FLYR …

Pioneering Swiss Law Firm OBERSON ABELS Goes Live on iManage Cloud
CHICAGO, April 17, 2025 (GLOBE NEWSWIRE) -- iManage, the company dedicated to Making Knowledge Work™, today announced that leading Swiss law firm OBERSON ABELS SA has successfully gone live on iManage Cloud, becoming the first Swiss law firm to adopt …

Q1 2025 as planned, post Financial restructuring: commercial recovery, decline in revenue and limited cash consumption
Press Release Q1 2025 as planned, post financial restructuring: commercial recovery, decline in revenue and limited cash consumption Confirmation of continued commercial recovery, fueled by strategic large deal signatures Q1 2025 order entry at €1.7 …

T1 2025 conforme aux prévisions, post restructuration financière : amélioration de l’activité commerciale, recul du chiffre d’affaires et consommation de trésorerie limitée
Communiqué de presse T1 2025 conforme aux prévisions, post restructuration financière : amélioration de l’activité commerciale, recul du chiffre d’affaires et consommation de trésorerie limitée Confirmation de la poursuite de la reprise commerciale, portée …

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for …

WISeKey, SEALSQ, OISTE Foundation, and the United Nations Alliance of Civilizations Unite to Launch HUMAN-AI-T, a Global Initiative to Embed Humanity into Artificial Intelligence UNAOC AI for #OneHumanity: Human-Centered Artificial Intell
WISeKey, SEALSQ, OISTE Foundation, and the United Nations Alliance of Civilizations Unite to Launch HUMAN-AI-T, a Global Initiative to Embed Humanity into Artificial Intelligence UNAOC AI for #OneHumanity: Human-Centered Artificial Intelligence Geneva, …

WISeKey, SEALSQ, la Fundación OISTE y la Alianza de Civilizaciones de las Naciones Unidas se unen para lanzar HUMAN-AI-T, una iniciativa global para integrar la humanidad en la inteligencia artificial UNAOC IA para #UnaHumanidad: Inteligen
WISeKey, SEALSQ, la Fundación OISTE y la Alianza de Civilizaciones de las Naciones Unidas se unen para lanzar HUMAN-AI-T, una iniciativa global para integrar la humanidad en la inteligencia artificial UNAOC IA para #UnaHumanidad: Inteligencia Artificial …

Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has continued to expand coverage for Ryoncil® (remestemcel-L), the first …

Advent Technologies Holdings Receives Nasdaq Notice on Late Filing of its Form 10-K
LIVERMORE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ADN). Advent Technologies Holdings, Inc. announced today that, as expected, it received a notice from Nasdaq on April 16, 2025, notifying the Company that it is not in compliance with the …